Evidence map›Paper›PMID 25129554›Full record

ArticleInternational journal of medical microbiology : IJMM2014

In vitro and in vivo cell invasion and systemic spreading of Mycoplasma agalactiae in the sheep infection model.

Shivanand Hegde, Shrilakshmi Hegde, Joachim Spergser, René Brunthaler, Renate Rosengarten, Rohini Chopra-Dewasthaly

Open access · hybridAbstract read
In one paragraph

Article in International journal of medical microbiology : IJMM, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Pathogens (Basel, Switzerland) · 2024
    Article
  5. Vaccines · 2024
    Review
  6. Unveiling the stealthy tactics: mycoplasma's immune evasion strategies.Frontiers in cellular and infection microbiology · 2023
    Review
  7. Article
  8. Serum Resistance ofPathogens (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Article
  11. Annexin A2 regulatesFrontiers in immunology · 2022
    Article
  12. Characterization of the interactome profiling ofFrontiers in microbiology · 2022
    Article
  13. Analysis of DnaK Expression from a Strain ofInternational journal of molecular sciences · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Early Corticosteroid Therapy forJournal of clinical medicine · 2019
    Article
  18. Review
  19. Article
  20. Antimicrobial Resistance inMicrobiology spectrum · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Shivanand HegdeDivision of Clinical Microbiology and Infection Biology, Institute of Bacteriology, Mycology and Hygiene, Department of Pathobiology, University of Veterinary Medicine, Veterinaerplatz 1, A-1210 Vienna, Austria.
Shrilakshmi HegdeDivision of Clinical Microbiology and Infection Biology, Institute of Bacteriology, Mycology and Hygiene, Department of Pathobiology, University of Veterinary Medicine, Veterinaerplatz 1, A-1210 Vienna, Austria.
Joachim SpergserDivision of Clinical Microbiology and Infection Biology, Institute of Bacteriology, Mycology and Hygiene, Department of Pathobiology, University of Veterinary Medicine, Veterinaerplatz 1, A-1210 Vienna, Austria.
René BrunthalerInstitute of Pathology and Forensic Veterinary Medicine, Department of Pathobiology; University of Veterinary Medicine, Veterinaerplatz 1, A-1210 Vienna, Austria.
Renate RosengartenDivision of Clinical Microbiology and Infection Biology, Institute of Bacteriology, Mycology and Hygiene, Department of Pathobiology, University of Veterinary Medicine, Veterinaerplatz 1, A-1210 Vienna, Austria.
Rohini Chopra-DewasthalyDivision of Clinical Microbiology and Infection Biology, Institute of Bacteriology, Mycology and Hygiene, Department of Pathobiology, University of Veterinary Medicine, Veterinaerplatz 1, A-1210 Vienna, Austria. Electronic address: Rohini.Chopra-Dewasthaly@vetmeduni.ac.at.
University of Veterinary Medicine Vienna · AT

Funding

Austrian Science Fund FWF P 21796Austrian Science Fund FWF P 23595
6 · The paper itself

Abstract

Generally regarded as extracellular pathogens, molecular mechanisms of mycoplasma persistence, chronicity and disease spread are largely unknown. Mycoplasma agalactiae, an economically important pathogen of small ruminants, causes chronic infections that are difficult to eradicate. Animals continue to shed the agent for several months and even years after the initial infection, in spite of long antibiotic treatment. However, little is known about the strategies that M. agalactiae employs to survive and spread within an immunocompetent host to cause chronic disease. Here, we demonstrate for the first time its ability to invade cultured human (HeLa) and ruminant (BEND and BLF) host cells. Presence of intracellular mycoplasmas is clearly substantiated using differential immunofluorescence technique and quantitative gentamicin invasion assays. Internalized M. agalactiae could survive and exit the cells in a viable state to repopulate the extracellular environment after complete removal of extracellular bacteria with gentamicin. Furthermore, an experimental sheep intramammary infection was carried out to evaluate its systemic spread to organs and host niches distant from the site of initial infection. Positive results obtained via PCR, culture and immunohistochemistry, especially the latter depicting the presence of M. agalactiae in the cytoplasm of mammary duct epithelium and macrophages, clearly provide the first formal proof of M. agalactiae's capability to translocate across the mammary epithelium and systemically disseminate to distant inner organs. Altogether, the findings of these in vitro and in vivo studies indicate that M. agalactiae is capable of entering host cells and this might be the strategy that it employs at a population level to ward off the host immune response and antibiotic action, and to disseminate to new and safer niches to later egress and once again proliferate upon the return of favorable conditions to cause persistent chronic infections.

Indexed as

EndocytosisAnimalsBacterial TranslocationCell LineCytosolDisease Models, AnimalFluorescent Antibody TechniqueHumansMastitisMicrobial ViabilityMycoplasma agalactiaeMycoplasma InfectionsSepsisSheepCell invasionImmunohistochemistryIntracellularMycoplasma agalactiaePersistenceSystemic spreading

Identifiers

PMID25129554
PMCPMC4282308
OpenAlexW2028318211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.